KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,640
+510 (4.20%)
At close: Jan 23, 2026
-22.97%
Market Cap137.86B
Revenue (ttm)90.11B
Net Income (ttm)174.16M
Shares Out10.91M
EPS (ttm)15.95
PE Ratio791.60
Forward PEn/a
Dividend50.00 (0.41%)
Ex-Dividend DateDec 29, 2025
Volume31,490
Average Volume18,467
Open12,050
Previous Close12,130
Day's Range12,050 - 12,650
52-Week Range11,940 - 18,710
Beta1.26
RSI45.58
Earnings Daten/a

About KOREA PHARMA

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 134
Stock Exchange KOSDAQ
Ticker Symbol 032300
Full Company Profile

Financial Performance

In 2024, KOREA PHARMA's revenue was 81.28 billion, a decrease of -2.36% compared to the previous year's 83.24 billion. Earnings were 3.79 billion, an increase of 4426.69%.

Financial Statements